RecruitingNCT04451551

Myocardial Perfusion Imaging by 15O-H2O PET/CT

Myocardial Perfusion Imaging by 15O-H2O PET/CT: Reference Values and Prognostic Value


Sponsor

University of Aarhus

Enrollment

5,000 participants

Start Date

Jun 23, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The trial will include 5000 patients with evident or suspected ischemic heart disease refered to Department of Nuclear Medicine \& PET Centre, Aarhus University Hospital, for perfusion imaging by 15O-H2O PET/CT scan of the heart during rest and stress. The patients will undergo the clinical scan as normal. Data from the scans will be used to determine reference values of the examination. Follow up will be done for up to 10 years in regards to major cardiovascular events in order to determine the prognostic value of the scan.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Known or suspected ischemic heart disease referred for a clinical H2O-PET at Department of Nuclear Medicine and PET Centre, Aarhus University Hospital

Exclusion Criteria1

  • Claustrophobia, severe asthma, younger than 18 years

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Aarhus University Hospital

Aarhus, Aarhus N, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04451551


Related Trials